AptarGroup, Inc. (ATR)

Market Cap	8.38B -14.4%
Revenue (ttm)	3.78B +5.4%
Net Income	392.79M +4.9%
EPS	5.89 +6.5%
Shares Out	63.77M
PE Ratio	22.31
Forward PE	23.75
Dividend	$1.92 (1.46%)
Ex-Dividend Date	Feb 4, 2026

Volume	424,118
Open	131.22
Previous Close	132.02
Day's Range	127.34 - 132.44
52-Week Range	103.23 - 164.28
Beta	0.49
Analysts	Buy
Price Target	170.25 (+29.57%)
Earnings Date	Apr 30, 2026

About ATR

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Apr 21, 1993
• Employees: 14,000
• Stock Exchange: NYSE
• Ticker Symbol: ATR
• Website: https://www.aptar.com

Financial Performance

In 2025, AptarGroup's revenue was $3.78 billion, an increase of 5.42% compared to the previous year's $3.58 billion. Earnings were $392.79 million, an increase of 4.87%.

Analyst Summary

According to 4 analysts, the average rating for ATR stock is "Buy." The 12-month stock price target is $170.25, which is an increase of 29.57% from the latest price.

Price Target

$170.25

(29.57% upside)

Analyst Consensus: Buy